Home/Filings/4/0001062993-24-009637
4//SEC Filing

Aklog Lishan 4

Accession 0001062993-24-009637

CIK 0001799011other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:00 PM ET

Size

5.1 KB

Accession

0001062993-24-009637

Insider Transaction Report

Form 4
Period: 2024-05-07
Aklog Lishan
DirectorChief Executive Officer
Transactions
  • Award

    Common stock

    2024-05-07+400,0001,166,627 total
Footnotes (2)
  • [F1]Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
  • [F2]Includes 142,227 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Dr. Aklog, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date.

Issuer

Lucid Diagnostics Inc.

CIK 0001799011

Entity typeother

Related Parties

1
  • filerCIK 0001665074

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:00 PM ET
Size
5.1 KB